Lv6
2260 积分 2023-09-20 加入
Accelerating and optimising CAR T-cell manufacture to deliver better patient products
11天前
已完结
CAR T Cells and T-Cell Therapies for Cancer
11天前
已完结
Safety and Anti-Tumor Activity of CD5 CAR T-Cells in Patients with Relapsed/Refractory T-Cell Malignancies
20天前
已完结
Safety and Anti-Tumor Activity of CD5 CAR T-Cells in Patients with Relapsed/Refractory T-Cell Malignancies
20天前
已关闭
The present and future for CAR-T cell therapy in adult B-cell ALL
20天前
已完结
The present and future for CAR-T cell therapy in adult B-cell ALL
20天前
已关闭
Past, present, and future of CRISPR genome editing technologies
20天前
已完结
Safety and efficacy of CD7-CAR-T cell in patients with relapsed/refractory T-lymphoblastic leukemia/lymphoma: Phase I dose-escalation/dose-expansion study
1个月前
已完结
Phase 1 Dose Escalation Study of the Anti-CD7 CAR-T Therapy in Relapsed/Refractory T-Cell Acute Leukemia and Lymphoblastic Lymphoma
1个月前
已关闭
Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy
1个月前
已完结
皖公网安备34019202002308
